| Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma EA Olsen, YH Kim, TM Kuzel, TR Pacheco, FM Foss, S Parker, SR Frankel, ... Journal of clinical oncology 25 (21), 3109-3115, 2007 | 1231 | 2007 |
| Nivolumab for metastatic renal cell carcinoma: results of a randomized phase II trial RJ Motzer, BI Rini, DF McDermott, BG Redman, TM Kuzel, MR Harrison, ... Journal of clinical oncology 33 (13), 1430-1437, 2015 | 1214 | 2015 |
| gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma DJ Schwartzentruber, DH Lawson, JM Richards, RM Conry, DM Miller, ... New England Journal of Medicine 364 (22), 2119-2127, 2011 | 1124 | 2011 |
| Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia CL Bennett, SM Silver, B Djulbegovic, AT Samaras, CA Blau, KJ Gleason, ... Jama 299 (8), 914-924, 2008 | 995 | 2008 |
| Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma E Olsen, M Duvic, A Frankel, Y Kim, A Martin, E Vonderheid, B Jegasothy, ... Journal of Clinical Oncology 19 (2), 376-388, 2001 | 792 | 2001 |
| Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial NB Haas, J Manola, RG Uzzo, KT Flaherty, CG Wood, C Kane, M Jewett, ... The Lancet 387 (10032), 2008-2016, 2016 | 710 | 2016 |
| NCCN task force report: oral chemotherapy SN Weingart, E Brown, PB Bach, K Eng, SA Johnson, TM Kuzel, ... Journal of the National Comprehensive Cancer Network 6 (S3), S-1-S-14, 2008 | 609 | 2008 |
| Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial HM Prince, YH Kim, SM Horwitz, R Dummer, J Scarisbrick, P Quaglino, ... The Lancet 390 (10094), 555-566, 2017 | 599 | 2017 |
| Pure red-cell aplasia and epoetin therapy CL Bennett, S Luminari, AR Nissenson, MS Tallman, SA Klinge, ... New England Journal of Medicine 351 (14), 1403-1408, 2004 | 563 | 2004 |
| Relation between literacy, race, and stage of presentation among low-income patients with prostate cancer. CL Bennett, MR Ferreira, TC Davis, J Kaplan, M Weinberger, T Kuzel, ... Journal of Clinical Oncology 16 (9), 3101-3104, 1998 | 533 | 1998 |
| Cutaneous Lymphoma International Consortium study of outcome in advanced stages of mycosis fungoides and Sézary syndrome: effect of specific prognostic markers on survival and … JJ Scarisbrick, HM Prince, MH Vermeer, P Quaglino, S Horwitz, P Porcu, ... Journal of Clinical Oncology 33 (32), 3766-3773, 2015 | 462 | 2015 |
| Kidney cancer RJ Motzer, N Agarwal, C Beard, GB Bolger, B Boston, MA Carducci, ... Journal of the National Comprehensive Cancer Network 7 (6), 618-630, 2009 | 447 | 2009 |
| Phase II study of single-agent gemcitabine in previously untreated patients with metastatic urothelial cancer. WM Stadler, T Kuzel, B Roth, D Raghavan, FA Dorr Journal of clinical oncology 15 (11), 3394-3398, 1997 | 437 | 1997 |
| Bladder cancer PE Clark, N Agarwal, MC Biagioli, MA Eisenberger, RE Greenberg, ... Journal of the National Comprehensive Cancer Network 11 (4), 446-475, 2013 | 426 | 2013 |
| Prostate cancer, version 2.2014 JL Mohler, PW Kantoff, AJ Armstrong, RR Bahnson, M Cohen, ... Journal of the National Comprehensive Cancer Network 12 (5), 686-718, 2014 | 419 | 2014 |
| Small cell carcinoma of the urinary bladder: a clinicopathologic analysis of 64 patients L Cheng, CX Pan, XJ Yang, A Lopez‐Beltran, GT MacLennan, H Lin, ... Cancer 101 (5), 957-962, 2004 | 399 | 2004 |
| Phase II trial of gemcitabine plus cisplatin in patients with metastatic urothelial cancer D Kaufman, D Raghavan, M Carducci, EG Levine, B Murphy, J Aisner, ... Journal of Clinical Oncology 18 (9), 1921-1927, 2000 | 336 | 2000 |
| Primary cutaneous T-cell lymphoma: review and current concepts RS Siegel, T Pandolfino, J Guitart, S Rosen, TM Kuzel Journal of Clinical Oncology 18 (15), 2908-2925, 2000 | 312 | 2000 |
| Treatment of mycosis fungoides with photochemotherapy (PUVA): long-term follow-up JJ Herrmann, HH Roenigk Jr, A Hurria, TM Kuzel, E Samuelson, ... Journal of the American Academy of Dermatology 33 (2), 234-242, 1995 | 307 | 1995 |
| Health literacy and shared decision making for prostate cancer patients with low socioeconomic status SP Kim, SJ Knight, C Tomori, KM Colella, RA Schoor, L Shih, TM Kuzel, ... Cancer investigation 19 (7), 684-691, 2001 | 300 | 2001 |
